Grifols S.A. ADR (G0FB)
FSX
Closed
Oct 9, 2026
Day's Range
6.5052 wk Range
5.95Overview - G0FB - Grifols S.A. ADR
Key Statistics
Valuation
Enterprise Value
19.96B
P/E (Trailing)
‪9.69‬
P/E (Forward)
‪11.85‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪0.58‬
Price / Book
‪1.57‬
EV / EBITDA
‪12.13‬
Profitability
Gross Margin
‪37.62%‬
Profit Margin
‪6.09%‬
Operating Margin
‪15.90%‬
Return on Assets
‪4.23%‬
Return on Equity
‪6.93%‬
Ownership
Shares Outstanding
680.58M
Float
836.44M
Held by Insiders
‪0.00%‬
Held by Institutions
‪57.10%‬
Price stats
Beta
‪1.19‬
50-Day Avg
‪6.56‬
200-Day Avg
‪6.85‬
Dividends
Payout Ratio
‪36.83%‬
Frequency
Annual
Market Cap - G0FB - Grifols S.A. ADR
Peers - G0FB - Grifols S.A. ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - G0FB - Grifols S.A. ADR
About
Grifols S.A. ADR is a healthcare and biotechnology asset representing Grifols’ U.S. depositary shares. Grifols is a global specialty plasma therapeutics company focused on the research, development, manufacturing, and distribution of plasma-derived medicines and related biopharmaceutical products. Its core activities…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
